Gurudatta Naik

Researcher Next ID · RN-025914

Researcher · Medicine

Adelaide, Australia

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Renal cell carcinoma treatment

Cancer Genomics and Diagnostics

Prostate Cancer Treatment and Research

Bladder and Urothelial Cancer Treatments

Renal and related cancers

Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53
Clinical Cancer Research · 2021 · 10.1158/1078-0432.ccr-21-0715
First-In-Human Phase 1 Clinical Trials – A Single-Center Experience In The Era Of Modern Oncotherapeutics
Scientific Reports · 2020 · 10.1038/s41598-020-64906-4
Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma
Journal for ImmunoTherapy of Cancer · 2019 · 10.1186/s40425-019-0621-1
Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
The Lancet Neurology · 2019 · https://doi.org/10.1016/s1474-4422(18)30468-x
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
The Lancet Neurology · 2018 · https://doi.org/10.1016/s1474-4422(18)30403-4
Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA
Cancer · 2018 · 10.1002/cncr.31314
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016
The Lancet Infectious Diseases · 2018 · https://doi.org/10.1016/s1473-3099(18)30362-1

No projects listed.